Morningside Venture Investments
Part of Morningside Group
Morningside Venture Investments Ltd is a Cayman Islands-registered investment vehicle used by the Chan family's Morningside organization to hold specific biotech equity stakes (it has filed SEC Schedule 13Ds as a direct holder in companies including Kezar Life Sciences, Apellis Pharmaceuticals, Liquidia, and Amylyx Pharmaceuticals). It is a distinct legal investing entity within the broader Morningside Group, the Hong Kong/US family holding company Gerald and Ronnie Chan co-founded in 1986.
Cayman Islands · 6+ investments · 3 portfolio companies
- Headquarters
- Cayman Islands
- Portfolio Companies
- 3
- Total Investments
- 6
- Last Investment
- Jul 2026
- Geographic Focus
- United States
Overview
Morningside Venture Investments is a Family Office firm based in Cayman Islands. It has made 6 investments, including EpiVax, Stealth Biotherapeutics and Origene. Focus areas include Biotech.
Morningside Group Family
Portfolio3
Co-investors8
Sign up to view co-investors
8 co-investors across 8 shared portfolio companies — who they back alongside, and how often they lead.
Venture Capital ×8 · 1 shared rounds
Investment History
Sign up to view investment history
Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.
Your firm? Embed this profile
Add the live badge to your site — it stays current as your portfolio data updates.
<a href="https://indexed.vc/investors/morningside-venture-investments"><img src="https://indexed.vc/api/badge/investor/morningside-venture-investments" alt="Morningside Venture Investments on Indexed.vc" width="260" height="76" /></a>